Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) Short Interest Update

Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) was the recipient of a large increase in short interest during the month of March. As of March 13th, there was short interest totalling 3,400 shares, an increase of 3,300.0% from the February 27th total of 100 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average daily volume of 7,400 shares, the days-to-cover ratio is currently 0.5 days.

XTNT stock opened at $0.64 on Friday. Xtant Medical has a 12 month low of $0.55 and a 12 month high of $3.55.

Xtant Medical (NYSEAMERICAN:XTNT) last released its quarterly earnings results on Thursday, March 5th. The medical device company reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.21) by $0.09. The business had revenue of $16.96 million during the quarter.

Xtant Medical Company Profile

Xtant Medical Holdings, Inc, formerly Bacterin International Holdings, Inc, develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment.

See Also: Gap Up Stocks

Receive News & Ratings for Xtant Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical and related companies with MarketBeat.com's FREE daily email newsletter.